0 Évaluations
ID

41484

Description

Clarithromycin Plus CTd Regimen for Patients With Newly Diagnosed Multiple Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT02248428

Lien

https://clinicaltrials.gov/show/NCT02248428

Mots-clés

Versions (1)
  1. 26/10/2020 26/10/2020 -
Détendeur de droits

see on clinicaltrials.gov

Téléchargé le

26 octobre 2020

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

  • Plus récent
  • Plus ancien
  • Favori
  • Plus récent
    • Plus récent
    • Plus ancien
    • Favori

    Aucun commentaire

    Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

    Eligibility Multiple Myeloma NCT02248428

    Anglais

    Eligibility Multiple Myeloma NCT02248428

    1 Formulaires  
    Inclusion Criteria
    Description

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    signed informed consent form
    Description

    Signed informed consent form

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0021430
    adhere to the study visit schedule and other protocol requirements
    Description

    Ability to meet study requirements

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0525058
    diagnosed with active multiple myeloma
    Description

    active multiple myeloma

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0205177
    UMLS CUI [1,2]
    C0026764
    myeloma previously untreated
    Description

    previously untreated

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0332155
    UMLS CUI [1,2]
    C0026764
    karnofsky performance status(kps) ≥50
    Description

    karnofsky performance status

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0206065
    karnofsky performance status (kps) <50 related to bony disease
    Description

    karnofsky performance status

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0206065
    UMLS CUI [1,2]
    C0439849
    UMLS CUI [1,3]
    C0005940
    new york heart association (nyha) functional ≤ class iii
    Description

    new york heart association

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C1275491
    Exclusion Criteria
    Description

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    hypersensitivity to clarithromycin or any of its excipients, erythromycin, or any of the macrolide antibiotics;
    Description

    hypersensitivity to clarithromycin or any of its excipients, erythromycin, or any of the macrolide antibiotics

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0020517
    UMLS CUI [1,2]
    C0055856
    UMLS CUI [2,1]
    C0020517
    UMLS CUI [2,2]
    C0055856
    UMLS CUI [2,3]
    C0015237
    UMLS CUI [3,1]
    C0020517
    UMLS CUI [3,2]
    C0014806
    UMLS CUI [4,1]
    C0020517
    UMLS CUI [4,2]
    C0003240
    concomitant administration of cisapride, pimozide, astemizole, terfenadine, ergotamine or dihydroergotamine, simvastatin, lovastatin, and atorvastatin;
    Description

    concomitant administration of cisapride, pimozide, astemizole, terfenadine, ergotamine or dihydroergotamine, simvastatin, lovastatin, and atorvastatin

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C2347852
    UMLS CUI [1,2]
    C0072916
    UMLS CUI [2,1]
    C2347852
    UMLS CUI [2,2]
    C0031935
    UMLS CUI [3,1]
    C2347852
    UMLS CUI [3,2]
    C0085170
    UMLS CUI [4,1]
    C2347852
    UMLS CUI [4,2]
    C0085173
    UMLS CUI [5,1]
    C2347852
    UMLS CUI [5,2]
    C0014710
    UMLS CUI [6,1]
    C2347852
    UMLS CUI [6,2]
    C0012291
    UMLS CUI [7,1]
    C2347852
    UMLS CUI [7,2]
    C0074554
    UMLS CUI [8,1]
    C2347852
    UMLS CUI [8,2]
    C0024027
    UMLS CUI [9,1]
    C2347852
    UMLS CUI [9,2]
    C0286651
    a history of cholestatic jaundice/hepatic dysfunction associated with prior use of clarithromycin
    Description

    previous cholestatic jaundice/hepatic dysfunction linked to use of clarithromycin

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0205156
    UMLS CUI [1,2]
    C0008370
    UMLS CUI [1,3]
    C0022346
    UMLS CUI [1,4]
    C0332281
    UMLS CUI [1,5]
    C0055856
    UMLS CUI [2,1]
    C0205156
    UMLS CUI [2,2]
    C0086565
    UMLS CUI [2,3]
    C0332281
    UMLS CUI [2,4]
    C0055856
    impaired renal function,creatinine ≥221umol/l；
    Description

    abnormal renal function, creatinine

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0201976
    UMLS CUI [2]
    C0151746
    pregnant or breast feeding females
    Description

    pregnant or breast feeding

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0032961
    UMLS CUI [2]
    C0006147
    any condition which places the subject at unacceptable risk if he/she were to participate in the study or confounds the ability to interpret data from the study.
    Description

    condition placing the subject at unacceptable risk in case of study participation or confounds the study's data interpretation

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0012634
    UMLS CUI [1,2]
    C2348568
    UMLS CUI [1,3]
    C1883420
    UMLS CUI [1,4]
    C0035647
    UMLS CUI [2,1]
    C0012634
    UMLS CUI [2,2]
    C0392760
    UMLS CUI [2,3]
    C0681873
    UMLS CUI [2,4]
    C0459471
    Retour au début de la page

    Similar models

    Eligibility Multiple Myeloma NCT02248428

    1 Formulaires
    Name
    Type
    Description | Question | Decode (Coded Value)
    Type de données
    Alias
    Item Group
    C1512693 (UMLS CUI)
    Signed informed consent form
    Item
    signed informed consent form
    boolean
    C0021430 (UMLS CUI [1])
    Ability to meet study requirements
    Item
    adhere to the study visit schedule and other protocol requirements
    boolean
    C0525058 (UMLS CUI [1])
    active multiple myeloma
    Item
    diagnosed with active multiple myeloma
    boolean
    C0205177 (UMLS CUI [1,1])
    C0026764 (UMLS CUI [1,2])
    previously untreated
    Item
    myeloma previously untreated
    boolean
    C0332155 (UMLS CUI [1,1])
    C0026764 (UMLS CUI [1,2])
    karnofsky performance status
    Item
    karnofsky performance status(kps) ≥50
    boolean
    C0206065 (UMLS CUI [1])
    karnofsky performance status
    Item
    karnofsky performance status (kps) <50 related to bony disease
    boolean
    C0206065 (UMLS CUI [1,1])
    C0439849 (UMLS CUI [1,2])
    C0005940 (UMLS CUI [1,3])
    new york heart association
    Item
    new york heart association (nyha) functional ≤ class iii
    boolean
    C1275491 (UMLS CUI [1])
    Item Group
    C0680251 (UMLS CUI)
    hypersensitivity to clarithromycin or any of its excipients, erythromycin, or any of the macrolide antibiotics
    Item
    hypersensitivity to clarithromycin or any of its excipients, erythromycin, or any of the macrolide antibiotics;
    boolean
    C0020517 (UMLS CUI [1,1])
    C0055856 (UMLS CUI [1,2])
    C0020517 (UMLS CUI [2,1])
    C0055856 (UMLS CUI [2,2])
    C0015237 (UMLS CUI [2,3])
    C0020517 (UMLS CUI [3,1])
    C0014806 (UMLS CUI [3,2])
    C0020517 (UMLS CUI [4,1])
    C0003240 (UMLS CUI [4,2])
    concomitant administration of cisapride, pimozide, astemizole, terfenadine, ergotamine or dihydroergotamine, simvastatin, lovastatin, and atorvastatin
    Item
    concomitant administration of cisapride, pimozide, astemizole, terfenadine, ergotamine or dihydroergotamine, simvastatin, lovastatin, and atorvastatin;
    boolean
    C2347852 (UMLS CUI [1,1])
    C0072916 (UMLS CUI [1,2])
    C2347852 (UMLS CUI [2,1])
    C0031935 (UMLS CUI [2,2])
    C2347852 (UMLS CUI [3,1])
    C0085170 (UMLS CUI [3,2])
    C2347852 (UMLS CUI [4,1])
    C0085173 (UMLS CUI [4,2])
    C2347852 (UMLS CUI [5,1])
    C0014710 (UMLS CUI [5,2])
    C2347852 (UMLS CUI [6,1])
    C0012291 (UMLS CUI [6,2])
    C2347852 (UMLS CUI [7,1])
    C0074554 (UMLS CUI [7,2])
    C2347852 (UMLS CUI [8,1])
    C0024027 (UMLS CUI [8,2])
    C2347852 (UMLS CUI [9,1])
    C0286651 (UMLS CUI [9,2])
    previous cholestatic jaundice/hepatic dysfunction linked to use of clarithromycin
    Item
    a history of cholestatic jaundice/hepatic dysfunction associated with prior use of clarithromycin
    boolean
    C0205156 (UMLS CUI [1,1])
    C0008370 (UMLS CUI [1,2])
    C0022346 (UMLS CUI [1,3])
    C0332281 (UMLS CUI [1,4])
    C0055856 (UMLS CUI [1,5])
    C0205156 (UMLS CUI [2,1])
    C0086565 (UMLS CUI [2,2])
    C0332281 (UMLS CUI [2,3])
    C0055856 (UMLS CUI [2,4])
    abnormal renal function, creatinine
    Item
    impaired renal function,creatinine ≥221umol/l；
    boolean
    C0201976 (UMLS CUI [1])
    C0151746 (UMLS CUI [2])
    pregnant or breast feeding
    Item
    pregnant or breast feeding females
    boolean
    C0032961 (UMLS CUI [1])
    C0006147 (UMLS CUI [2])
    condition placing the subject at unacceptable risk in case of study participation or confounds the study's data interpretation
    Item
    any condition which places the subject at unacceptable risk if he/she were to participate in the study or confounds the ability to interpret data from the study.
    boolean
    C0012634 (UMLS CUI [1,1])
    C2348568 (UMLS CUI [1,2])
    C1883420 (UMLS CUI [1,3])
    C0035647 (UMLS CUI [1,4])
    C0012634 (UMLS CUI [2,1])
    C0392760 (UMLS CUI [2,2])
    C0681873 (UMLS CUI [2,3])
    C0459471 (UMLS CUI [2,4])
    Retour au début de la page 

    Aide

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial